KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Astrazeneca (AZN) Assets Average (2016 - 2025)

Historic Assets Average for Astrazeneca (AZN) over the last 17 years, with Q4 2025 value amounting to $114.3 billion.

  • Astrazeneca's Assets Average rose 936.7% to $114.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $114.3 billion, marking a year-over-year increase of 936.7%. This contributed to the annual value of $109.1 billion for FY2025, which is 631.48% up from last year.
  • According to the latest figures from Q4 2025, Astrazeneca's Assets Average is $114.3 billion, which was up 936.7% from $113.4 billion recorded in Q3 2025.
  • In the past 5 years, Astrazeneca's Assets Average ranged from a high of $114.3 billion in Q4 2025 and a low of $50.2 billion during Q1 2022
  • Moreover, its 5-year median value for Assets Average was $97.5 billion (2022), whereas its average is $92.8 billion.
  • As far as peak fluctuations go, Astrazeneca's Assets Average plummeted by 1355.07% in 2022, and later soared by 9244.45% in 2023.
  • Over the past 5 years, Astrazeneca's Assets Average (Quarter) stood at $53.7 billion in 2021, then surged by 77.65% to $95.3 billion in 2022, then increased by 3.43% to $98.6 billion in 2023, then increased by 5.96% to $104.5 billion in 2024, then rose by 9.37% to $114.3 billion in 2025.
  • Its Assets Average was $114.3 billion in Q4 2025, compared to $113.4 billion in Q3 2025 and $109.3 billion in Q2 2025.